Search Stories | HemAware

If Teens Don’t Snooze, They Lose

For teens, sleeping is as important as socializing. But about four out of five middle and high schools start before...

New Data on Disability

When the Behavioral Risk Factor Surveillance System added five functional disability types to a survey, the answers people gave were...

Taking Charge

Senior Screenings for Brain Health

A 2015 consensus panel of the International Association of Gerontology and Geriatrics agreed that it was time for all seniors...

Taking Charge

New Tax-Free Accounts for People with Disabilities

Until now, people with a disability could only keep $2,000 in a savings account if they wanted to stay on...

Family Matters

Energy Drinks: Hazardous to Kids’ Health

With their sleek, shiny cans and cool logos, energy drinks entice kids and teens by the millions. Despite their claims...

Fitness & Nutrition

Safe Arthritis Supplements

Some people swear by supplements to ease the ache of their arthritic joints. Be sure yours are safe and effective...

Taking Charge

Doctor looking out from behind lab shelving

Above and Beyond

“THINK BETTER. THINK BIGGER. THINK BEYOND.” These are the themes Steven W. Pipe, MD, laid out in summer 2015 as...

Advocacy

Taking a Peek at Pharmacokinetic (PK) Studies

Prophylaxis, a treatment regimen of regular factor infusions, ideally prevents bleeding in the average person with a moderate/severe bleeding disorder...

Taking Charge

Rare Finds

They’re the rarest of the rare: bleeding disorders like platelet storage pool disorder and factor XIII deficiency that affect only...

Community in Action

Making It Work

Whether you are in the midst of your career or just starting the job hunt, young adults with bleeding disorders...

Generation Next

Find Meaning Through Volunteering

Many Americans, including many retirees, spend significant hours volunteering. According to the Corporation for National and Community Service (CNCS), a...

Adults & Aging

FDA in Action

Updates on Daklinza, Technivie, and the ACE910 trial

Novel Technologies